RFP QuestBeta
OpenStage · pipeline

MEDICINES and HEALTHCARE PRODUCTS REGULATORY AGENCY

Recombinant Antibodies in a Customer Made Formulation

Laboratory EquipmentCPV 38000000 33000000
ValueValue not published
Deadline
Published14 Sept 2015
RegionEast of England
Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

We have a requirement to purchase 1 g of the following 5 recombinant antibodies in a custom made formulation (buffer to be defined at a later stage): Anti-CD52 [Campath-1H], Human IgG1 Anti-CD3 epsilon [OKT-3 (muromonab)], Mouse IgG2A Anti- Keyhole limpet hemocyanin (KLH), Mouse IgG2A Anti-KLH, Human IgG1 Anti-KLH, Human IgG4

Buyer intelligence

Make the case to bid

Reveal who to approach at MEDICINES and HEALTHCARE PRODUCTS REGULATORY AGENCY, and generate a go-to-market strategy from their news, accounts and people.

Deep dive · beta

The full intelligence dossier

Our agent reads MEDICINES and HEALTHCARE PRODUCTS REGULATORY AGENCY’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.

Source & provenance
OCID
94d7c09b-fc7c-4276-b1cd-e1ebb8a4e324
Stage
pipeline · Closed
Source
Contracts Finder
Buyer ref
P-1032
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Laboratory & Precision Equipment

Scroll to explore the market network

MEDICINES and HEALTHCARE PRODUCTS REGULATORY AGENCY’s tender network

Assembling the network…